Article Text
Statistics from Altmetric.com
QUESTION: In patients with heroin dependence, is buprenorphine added to intensive cognitive behavioural therapy effective?
Design
Randomised (allocation concealed*), blinded {patients, clinicians and data collectors}†,* placebo controlled trial with follow up at 1 year.
Setting
The chemical dependence unit of an addiction centre in Stockholm, Sweden.
Patients
40 patients ≥20 years of age (mean age 30 y, 73% men) with an opiate dependence who were seeking admission for medically assisted heroin withdrawal and had ≥1 year of heroin dependence (DSM-IV criteria). Exclusion criteria were eligibility for methadone maintenance treatment in Sweden (≥4 y of multiple daily heroin use objectively documented in hospital records and ≥3 unsuccessful attempts in abstinence oriented treatment); codependence on alcohol, amphetamines, cannabinoids, or benzodiazepines; neurological disorders; dementia; cognitive impairment; psychosis; or other psychiatric disorder (unless the patient was stable and on treatment not contraindicated to buprenorphine). All patients were included in the analysis.
Intervention
20 patients were allocated to sublingual buprenorphine, …
Footnotes
-
Sources of funding: Swedish Medical Council and US National Institutes of Health.
-
For correspondence: Dr M Heilig, Karolinska Institute, Stockholm, Sweden. Markus.heilig{at}neurotec.ki.se
-
↵† Information provided by author.